For example, FBLN5 and MFAP4 were reproducibly observed to be significantly differentially expressed in the independent validation set of BE lesions, while CRNN and KRT6B were once again preferentially detected in the adjacent control tissue specimens (Table S5). This evidence concerns the gene FBLN5 and Barrett esophagus.